Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells

International Journal of Cancer

Volumn 130, Issue 1, 2012, Pages 1-9

  Maiti, Amit K ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

drug resistance; ROS; ROS maintaining genes

Indexed keywords

ANTHOCYANIDIN DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BARDOXOLONE METHYL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA PHENYL ETHYL ISOTHIOCYANATE; BUTEIN; CELASTROL; CHLORAMBUCIL; CHRYSOPHENOL; CIBROSTATIN 6; CISPLATIN; MENADIONE; NONSTRUCTURAL PROTEIN 1; NSC 741909; PARTHONALIDE; PHX 3; PIGMENT EPITHELIUM DERIVED FACTOR; REACTIVE OXYGEN METABOLITE; ROMIDEPSIN; ROSMARINIC ACID; ROTENONE; SULFORAPHANE; TANSHINONE IIA; THERMOQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN; VIRUS PROTEIN H 1; ZOLEDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CARCINOGENESIS; CELL METABOLISM; COLORECTAL CANCER; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG SENSITIZATION; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; MITOCHONDRIAL RESPIRATION; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; OXIDATIVE STRESS;

EID: 80255129401     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26306     Document Type: Review

References (69)

1. Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P,. Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 2007; 14: 195-208.
2. Donnenberg VS, Donnenberg AD,. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 2005; 45: 872-7. (Pubitemid 41060226)
3. Ladiges W, Wanagat J, Preston B, Loeb L, Rabinovitch P,. A Mitochondrial view of aging, reactive oxygen species and metastatic cancer. Aging Cell 2010;9:462-465.
4. Liou GY, Storz P,. Reactive oxygen species in cancer. Free Radic Res 2010; 44: 479-96.
5. Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, Sandaltzopoulos R,. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett 2008; 266: 12-20.
6. Lage H,. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 2008; 65: 3145-67.
7. Chaiswing L, Oberley TD,. Extracellular/microenvironmental redox state. Antioxid Redox Signal 2010;13:449-465.
8. Maulucci G, Pani G, Fusco S, Papi M, Arcovito G, Galeotti T, Fraziano M, De Spirito M,. Compartmentalization of the redox environment in PC-12 neuronal cells. Eur Biophys J 2010; 39: 993-9.
9. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GR, Chandel NS,. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 2010; 107: 8788-93.
10. Trachootham D, Alexandre J, Huang P,. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579-91.
11. Caraglia M, Budillon A, Tagliaferri P, Marra M, Abbruzzese A, Caponigro F,. Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. Curr Drug Targets 2005; 6: 301-23. (Pubitemid 40667797)
12. Gottlieb E, Vousden KH,. p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol 2010; 2: a001040.
13. Han YH, Moon HJ, You BR, Park WH,. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione. Food Chem Toxicol 2010; 48: 271-6.
14. Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, Sgroi D, Ellisen LW,. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 4675-80.
15. Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK, Kohno K, Mitra S, Bhakat KK,. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 2008; 28: 7066-80.
16. Verschoor ML, Wilson LA, Singh G,. Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 2010; 88: 204-19.
17. Turk D, Szakacs G,. Relevance of multidrug resistance in the age of targeted therapy. Curr Opin Drug Discov Dev 2009; 12: 246-52.
18. Bechtel W, Bauer G,. Modulation of intercellular ROS signaling of human tumor cells. Anticancer Res 2009; 29: 4559-70.
19. Lau AT, Wang Y, Chiu JF,. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem 2008; 104: 657-67. (Pubitemid 351671652)
20. Pani G, Galeotti T, Chiarugi P,. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010; 29: 351-78.
21. Fang J, Seki T, Maeda H,. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 2009; 61: 290-302.
22. Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH,. Propyl gallate inhibits the growth of HeLa cells via caspase-dependent apoptosis as well as a G1 phase arrest of the cell cycle. Oncol Rep 2010; 23: 1153-8.
23. Maiti AK,. Gene network analysis of oxidative stress-mediated drug sensitivity in resistant ovarian carcinoma cells. Pharmacogenomics J 2010; 10: 94-104.
24. Ushio-Fukai M, Nakamura Y,. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 2008; 266: 37-52. (Pubitemid 351753035)
25. Marra M, Santini D, Meo G, Vincenzi B, Zappavigna S, Baldi A, Rosolowski M, Tonini G, Loeffler M, Lupu R, Addeo SR, Abbruzzese A, et al,. Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells. Int J Cancer 2009; 125: 2004-13.
26. Caraglia M, Marra M, Leonetti C, Meo G, D'Alessandro AM, Baldi A, Santini D, Tonini G, Bertieri R, Zupi G, Budillon A, Abbruzzese A,. R115777 (Zarnestra)/zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation. J Cell Physiol 2007; 211: 533-43. (Pubitemid 46580107)
27. Santini D, Caraglia M, Vincenzi B, Holen I, Scarpa S, Budillon A, Tonini G,. Mechanisms of disease: preclinical reports of antineoplastic synergistic action of bisphosphonates. Nat Clin Pract Oncol 2006; 3: 325-38. (Pubitemid 43871543)
28. Hristov G, Kramer M, Li J, El-Andaloussi N, Mora R, Daeffler L, Zentgraf H, Rommelaere J, Marchini A,. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J Virol 2010; 84: 5909-22.
29. Wu XJ, Hua X,. Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther 2007; 6: 646-7. (Pubitemid 47328341)
30. Wei X, Guo W, Wu S, Wang L, Huang P, Liu J, Fang B,. Oxidative stress in NSC-741909-induced apoptosis of cancer cells. J Transl Med 2010; 8: 37.
31. Sung B, Park B, Yadav VR, Aggarwal BB,. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J Biol Chem 2010; 285: 11498-507.
32. Deng YT, Huang HC, Lin JK,. Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog 2010; 49: 141-51.
33. Hoyt MT, Palchaudhuri R, Hergenrother PJ,. Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism. Invest New Drugs 2010;29:562-573.
34. El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, Schneider-Stock R, Gali-Muhtasib H,. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 2010; 15: 183-95.
35. Indran IR, Hande MP, Pervaiz S,. Tumor cell redox state and mitochondria at the center of the non-canonical activity of telomerase reverse transcriptase. Mol Aspects Med 2010; 31: 21-8.
36. Sastre-Serra J, Valle A, Company MM, Garau I, Oliver J, Roca P,. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic Biol Med 2010; 48: 506-12.
37. Wang HJ, Wei XF, Jiang YY, Huang H, Yang Y, Fan SM, Zang LH, Tashiro S, Onodera S, Ikejima T,. Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells. Free Radic Res 2010; 44: 577-84.
38. Zhang JW, Rubio V, Zheng S, Shi ZZ,. Knockdown of OLA1, a regulator of oxidative stress response, inhibits motility and invasion of breast cancer cells. J Zhejiang Univ Sci B 2009; 10: 796-804.
39. Beck R, Pedrosa RC, Dejeans N, Glorieux C, Leveque P, Gallez B, Taper H, Eeckhoudt S, Knoops L, Calderon PB, Verrax J,. Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study. Invest New Drugs 2010 (epub ahead of print).
40. Moon DO, Kim MO, Lee JD, Choi YH, Kim GY,. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells. Cancer Lett 2010; 288: 183-91.
41. Chiu TL, Su CC,. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med 2010; 25: 231-6.
42. You BR, Park WH,. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol In Vitro 2010;24:1356-1362.
43. Zheng CL, Che XF, Akiyama S, Miyazawa K, Tomoda A,. 2-Aminophenoxazine-3- one induces cellular apoptosis by causing rapid intracellular acidification and generating reactive oxygen species in human lung adenocarcinoma cells. Int J Oncol 2010; 36: 641-50.
44. Das GC, Bacsi A, Shrivastav M, Hazra TK, Boldogh I,. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity. Mol Carcinog 2006; 45: 635-47. (Pubitemid 44406634)
45. Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti G, Passamonti S,. Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys 2010;501:151-157.
46. Deeb D, Gao X, Jiang H, Janic B, Arbab AS, Rojanasakul Y, Dulchavsky SA, Gautam SC,. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. Biochem Pharmacol 2010; 79: 350-60.
47. Shanmugam R, Kusumanchi P, Cheng L, Crooks P, Neelakantan S, Matthews W, Nakshatri H, Sweeney CJ,. A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species. Prostate 2010; 70: 1074-86.
48. Lu CC, Yang JS, Huang AC, Hsia TC, Chou ST, Kuo CL, Lu HF, Lee TH, Wood WG, Chung JG,. Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res 2010;54:967-976.
49. Moon DO, Kim MO, Choi YH, Hyun JW, Chang WY, Kim GY,. Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation. Cancer Lett 2010; 288: 204-13.
50. Choudhary S, Rathore K, Wang HC,. Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells. J Cancer Res Clin Oncol 2010;137:471-480.
51. Yang J, Chen S, Huang X, Han J, Wang Q, Shi D, Cheng R, Gao G, Yang X,. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis. Cancer Biol Ther 2010; 9:967-974.
52. Meeran SM, Patel SN, Tollefsbol TO,. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 2010; 5: e11457.
53. Yang J, Xiao YL, He XR, Qiu GF, Hu XM,. Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells. J Asian Nat Prod Res 2010; 12: 185-93.
54. Boldogh I, Roy G, Lee MS, Bacsi A, Hazra TK, Bhakat KK, Das GC, Mitra S,. Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress. Toxicology 2003; 193: 137-52. (Pubitemid 37340149)
55. Bechtel W, Bauer G,. Catalase protects tumor cells from apoptosis induction by intercellular ROS signaling. Anticancer Res 2009; 29: 4541-57.
56. Eidus L, Emel'ianov MO, Korystova AF, Kublik LN, Shaposhnikova VV, Korystov Iu N,. Multidrug resistance increase of tumor cells at the effect of radiation and phorbol ether depends on protein kinase C and reactive oxygen species. Radiats Biol Radioecol 2010; 50: 37-41.
57. Svineng G, Ravuri C, Rikardsen O, Huseby NE, Winberg JO,. The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect Tissue Res 2008; 49: 197-202.
58. Aghajanian A, Wittchen ES, Campbell SL, Burridge K,. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 2009; 4: e8045.
59. Vigil D, Cherfils J, Rossman KL, Der CJ,. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 2010; 10: 842-57.
60. Chaney SG, Sancar A,. DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 1996; 88: 1346-60. (Pubitemid 26329752)
61. Klaunig JE, Kamendulis LM, Hocevar BA,. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 2010; 38: 96-109.
62. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI,. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008; 266: 6-11.
63. Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, Sperlongano P, Vincenzi B, Naviglio S, Prete SD, Abbruzzese A, Stiuso P,. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis 2011; 2: e150.
64. Fang J, Nakamura H, Iyer AK,. Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 2007; 15: 475-86. (Pubitemid 47213870)
65. Ralph SJ, Rodriguez-Enriquez S, Neuzil J, Moreno-Sanchez R,. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 2010; 31: 29-59.
66. Kachadourian R, Brechbuhl HM, Ruiz-Azuara L, Gracia-Mora I, Day BJ,. Casiopeina IIgly-induced oxidative stress and mitochondrial dysfunction in human lung cancer A549 and H157 cells. Toxicology 2010; 268: 176-83.
67. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA,. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 2003; 23: 8576-85. (Pubitemid 37433363)
68. Chen Y, Bathula SR, Li J, Huang L,. Multi-functional nanoparticles delivering siRNA and doxorubicin overcome drug resistance in cancer. J Biol Chem;285:22639-22650.
69. Khaitan D, Dwarakanath BS,. Endogenous and induced oxidative stress in multi-cellular tumour spheroids: implications for improving tumour therapy. Indian J Biochem Biophys 2009; 46: 16-24.